GINA WADMAN: Open Payments
NPI 1871322354 · NEW BRITAIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 36 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $182 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| MILLICENT US INC | 9 | $182 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $121 |
| Astellas Pharma US Inc | 3 | $100 |
| Exact Sciences Corporation | 4 | $91 |
| Exeltis, USA Inc. | 4 | $83 |
| Organon LLC | 3 | $80 |
| Sage Therapeutics, LLC | 3 | $73 |
| CooperSurgical, Inc. | 3 | $57 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
Products named: BIJUVA, FEMLYV, Veozah, SLYND, ZURZUVAE, Cologuard Collection Kit, Paragard T 380A, INJECTAFER.
Industry payments across CT — which companies pay providers there.
